Selective CDK4/6 Inhibitors in Cancer: Moving Beyond Breast Cancer

Learning Module - Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, discuss the supporting rationale and emerging role of selective CDK4/6 inhibitors in multiple types of cancer.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research